May 6, 2020: Pharmaceutical Manufacturers: COVID-19 Impact on Cancer Care and Road to Recovery

AVBCC COVID-19 Webcast Series Replays, COVID-19

Featuring:

Roy Baynes, MD, PhD
Head, Global Clinical Development
Chief Medical Officer
Merck Research Laboratories
Rena Goins
Executive Director
Global Trade
GPO & Distribution Regeneron Healthcare Solutions, Inc.
Mark Hagler, MBA
Senior Vice President
Business Unit Head
US Oncology, Sun Pharma
Bruce Wilson
Head
Access Strategy
US Oncology
AstraZeneca
Bryon Wornson
VP
Oncology Patient and Health Impact Lead
Pfizer
Burt Zweigenhaft, PhD, D.Litt
Editor-in-Chief, VBCC;
Executive Vice President, FFF Enterprises;
Executive Director and Co-Founder, Association for Value-Based Cancer Care
Pharmaceutical support and innovation are vital to the effective treatment of patients with cancer. In this discussion, moderated by Burt Zweigenhaft, PhD, D.Litt, a panel of experts discussed the importance of maintaining an adequate supply of medicines for patients, and the need for philanthropic programs to ensure patients will be able to continue their medications, even if they lose their health insurance.

Related Articles

mRNA COVID-19 Vaccine Appears Safe and Effective in Patients with Cancer Receiving Active Treatment
By Chase Doyle
COVID-19
February 2022, Vol 13, No 1 Online Only
Read Article
Current and Future Effects of the COVID-19 Pandemic on Cancer Care
By Phoebe Starr
COVID-19
June 2021, Vol 12, No 3
Read Article
Later Diagnoses, Worse Outcomes in Patients with Lung Cancer During COVID-19 May Last
By Walter Alexander
COVID-19, Lung Cancer
April 2021, Vol 12, No 2
Read Article

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.